Preprint Article Version 1 This version is not peer-reviewed

Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe

Version 1 : Received: 30 October 2024 / Approved: 31 October 2024 / Online: 31 October 2024 (08:43:06 CET)

How to cite: Matsuoka, T.; Kobayashi, N.; Itohara, T.; Hara, Y. Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe. Preprints 2024, 2024102515. https://doi.org/10.20944/preprints202410.2515.v1 Matsuoka, T.; Kobayashi, N.; Itohara, T.; Hara, Y. Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe. Preprints 2024, 2024102515. https://doi.org/10.20944/preprints202410.2515.v1

Abstract

The therapeutic applicability of mesenchymal stem cells (MSC) for a range of conditions has garnered increasing interest. This study aimed to evaluate the mean major adverse cardiac and cerebrovascular event (MACCE)-free period in a population of 2,504 patients (age, 54.09 ± 11.65 years) receiving MSC therapy (mean dose, 1.49 ± 0.75 billion cells) for various indications (over two-thirds [n=1,700, 67.89%] received MSC therapy as an anti-ageing therapy) and evaluate for potential risk factors for MACCE development in this cohort. In multivariate Cox proportional hazards regression analysis, age, but not sex and MSC dose, was significantly associated with MACCE risk (hazard ratio=1.127; 95% confidence interval=1.0418, 1.219; p=0.0029). The adverse event rate was 0.8%, and none of the reported adverse events were severe. In conclusion, our study showed that stem cell therapy was safe in a large cohort of individuals and was associated with a low rate of MACCE.

Keywords

Mesenchymal Stem Cells; MACCE (Major Adverse Cardiac and Cerebrovascular Events); Anti-Aging Therapy; Intravenous Administration

Subject

Medicine and Pharmacology, Transplantation

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.